《Table 3Adverse events,serious adverse events,and concurrent treatment.》
提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《特力阿扎维林治疗新冠病毒肺炎的疗效与安全性——一项随机对照试验》
Serious adverse events occurred in a total of nine patients，with four events in the TZV group and five events in the placebo group.One patient in the TZV group developed arrhythmia after taking the study drug.One death occurred in the placebo group，while nobody in the TZV group died.The patient who died during the trial was a 70-year-old man；his condition worsened on the day of enrollment，with his blood oxygen saturation dropping down to 83%.Upon adjusting the flow rate of oxygen to 7 Láminà1，his blood oxygen saturation was maintained at 90%and his oxygenation index was less than 300 mm Hg.Chest CT examination revealed a serious chest inflammation with 75%pulmonary shadow.The patient was transferred to the ICU the day after the enrollment day，and his condition continued to worsen with the development of severe respiratory and circulatory failure.The patient died on the third day after randomization （Table 3）.
| 图表编号 | XD00195693700 严禁用于非法目的 |
|---|---|
| 绘制时间 | 2020.10.01 |
| 作者 | 吴效科、于凯江、王永晨、徐万海、马红丽、侯艳、李悦、蔡本志、朱丽影、张敏、胡晓丽、高敬书、王宇、秦慧超、王文杰、赵鸣雁、吴霞、张勇、李璐、李康、杜智敏、Ben Willem J.Mol、杨宝峰 |
| 绘制单位 | College of Pharmacology, Harbin Medical University、Heilongjiang Provincial Hospital, Harbin Institute of Technology、First Affiliated Hospital, Heilongjiang University of Chinese Medicine、First Affiliated Hospital, Harbin Medical University、Second Affiliat |
| 更多格式 | 高清、无水印（增值服务） |
